Drugs · acquisition-cost intelligence
Phenytek
extended phenytoin sodium· ingredient phenytoinHydantoin derivatives· PHENYTOIN SODIUM 200 mg/1; PHENYTOIN SODIUM 300 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$1.75
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 5 weeks.
2025-12-172026-04-22
Same-ingredient options by acquisition cost
Other phenytoin products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Dilantin-125 | $0.08371 | −$1.66 |
| DILANTIN | $0.14348 | −$1.60 |
| Dilantin Infatabs | $0.18917 | −$1.56 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.